Learn More
Apexbio Technology LLC BMS-708163 (Avagacestat) 1146699-66-2 50mg

Supplier: Apexbio Technology LLC A402250
BMS-708163 (Avagacestat CAS 1146699-66-2) is an orally bioavailable small-molecule inhibitor selectively targeting -secretase an enzyme responsible for amyloid precursor protein (APP) cleavage into neurotoxic amyloid-beta (A ) species associated with Alzheimer s disease pathology It demonstrates potent inhibitory activity (IC50 0 3 nM) effectively reducing A 40 and A 42 production in vitro in H4-8Sw cells Relative selectivity testing indicates a substantially lower inhibitory effect (approximately 190-fold weaker) toward Notch signaling compared to APP processing In animal models oral administration significantly reduces A levels in plasma cerebrospinal fluid and brain tissues underpinning its application in Alzheimer s disease research
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.